Gastroenterology CE Activities

Gastroenterology blog

View Details

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

Choosing the correct first therapy for your patients with ulcerative colitis (UC) can be tricky, but it is important because it gives them the best chance at a better life with UC. Getting it right early increases their odds of remission and reduces their risk of progression, hospitalization, and colectomy. Here are 6 ways to help get it right the first time.
View Details

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Over the past couple of years, several clinical decision support tools (CDSTs) have emerged to more effectively risk stratify patients and one actually predicts their response to certain biologics before they even start them.

RMEI Presentations

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty

The Gastroenterology Learner Pathway in IBD: An Outcomes-Based Iterative Approach to IBD Education Using Advanced Analytics and Predictive Modeling to Sustain Behavioral Change

LATEST Gastroentrology ARTICLES

RSS feed: Latest Gastroentrology Articles Latest Gastroentrology Articles
  • What the Robot Still Can’t Do November 14, 2026
    A primary care physician, stumped by a patient’s chronic condition, turns to AI for a diagnosis and treatment recommendation — but discovers the essential role that must still be played by a human doctor.
    Shantanu Nundy
  • Interferon-γ Underlying Thymoma-Associated Immune Dysregulation November 12, 2026
    In an observational study, thymoma-associated immune dysregulation was characterized by interferon-γ pathway activation. Four patients with severe disease treated with Janus kinase 1/2 inhibitors had clinical and biomarker responses.
    Iivo Hetemäki, Chen Wang, Rachel Wu, Joseph Pechacek, Taura Webb, Deanna Riley, Lucas dos Santos Dias, Heather Moorman, Princess Barber, Lindsey B. Rosen, Annalie Harris, Sebastian Ochoa, Karthik Darma, Maria Semenova, Laercio Lopez Da Silva, Kai Kisand, Tovah E. Markowitz, Peter D. Burbelo, Monika Fischer, Mark Raffeld, Tyler Hulett, Jennifer Stoddard, Sergio D. Rosenzweig, Christopher G. Kanakry, Kathy L. McGraw, Joseph Rocco, Luigi D. Notarangelo, Christa S. Zerbe, Ivan Fuss, Anjali Rai, Theo Heller, Patrick J. Loehrer, Eliisa Kekäläinen, Alexandra F. Freeman, Arun Rajan, Timi Martelius, Katherine R. Calvo, Steven M. Holland, Roderick Marion, Stefania Pittaluga, Michail S. Lionakis
  • A Liver-Targeted CIDEB siRNA in Adults with MASLD November 8, 2026
    A single dose of an siRNA targeting liver expression of CIDEB was associated with a reduction in liver fat of 58 to 80% at week 36 after treatment in persons with metabolic dysfunction–associated steatotic liver disease.
    Thomas D. Norton, Jorg Taubel, Gavin H. Imperato, Sonya Aziz-Zaman, Jane Witkin, Jutta Miller, Kusha A. Mohammadi, Shunguang Wang, Terri Swanson, Madison Stoms, Xiping Cheng, Jessica D’Antonio, Shehla Habib, David Workman, Justin Cho, Yogesh Patel, Vidya Xavier, Chao Chen, David J. Smith, Sean Smith, Susana Pereira, Donato Forlenza, Joette Pindar, Meredith Crosby, Shawn Fidotta, Mauricio Leal, Fady Tanios, Viktoria Gusarova, Mark Sleeman, Jennifer Hamilton, John Davis, Dinko Gonzalez Trotter, Rong Liu, Bret Musser, Ed Cox, Ned Braunstein, Niek Verweij, Luca A. Lotta, George D. Yancopoulos, Aris Baras, Gary A. Herman, David J. Lederer, for the ALN-CIDEB-NASH-2486 Study Investigators, Regeneron Genetics Center (RGC), Geisinger Health System–RGC DiscovEHR Collaboration, Penn Medicine Biobank, Colorado Center for Personalized Medicine, Mayo Clinic–RGC Project Generation, Malmö Diet and Cancer Study, Indiana University School of Medicine (Indiana-CLDB), UCLA Health–RGC ATLAS Collaboration, Mount Sinai Million Health Discoveries Program, and the University of Texas Southwestern, Dallas Biobank*

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Previously Published CE Activities